Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page has been updated to include new collaborators and a revised version number, while significant details about the study's purpose and methodology have been removed.SummaryDifference32%
- Check10 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check68 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check75 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check89 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.